Related Experiment Video
Updated: May 15, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Developing risk-based quality control plans: an overview of CLSI EP23-A
1nils.person@verizon.net
Clinical laboratory quality control (QC) now includes managing risks of incorrect patient results. This article details developing and using a risk-based QC plan, referencing the Clinical and Laboratory Standards Institute
Area of Science:
- Clinical Laboratory Science
- Quality Management Systems
Background:
- Quality control (QC) in clinical laboratories has evolved beyond traditional QC sample testing.
- There is an increasing focus on managing the risks associated with reporting inaccurate patient results.
- Risk management techniques are crucial for implementing an expanded QC vision.
Purpose of the Study:
- To outline the steps for developing a risk-based quality control (QC) plan.
- To provide guidance on implementing and utilizing a risk-based QC strategy in clinical laboratories.
- To build upon the foundation laid by the Clinical and Laboratory Standards Institute (CLSI) EP23-A guideline.
Main Methods:
- The article outlines a systematic approach to risk-based QC plan development.
- It details the practical application of risk management principles within the clinical laboratory setting.
- Guidance is provided based on the EP23 model for laboratory quality control.
Main Results:
- A clear framework for creating and employing risk-based QC plans is presented.
- The methodology facilitates proactive identification and mitigation of potential errors in patient testing.
- Implementation of this model enhances overall laboratory quality and patient safety.
Conclusions:
- Risk-based quality control is essential for modern clinical laboratories.
- Adopting a risk-based approach improves the management of potential errors in patient results.
- The EP23 model provides a robust framework for developing effective QC plans.
Related Concept Videos
Introduction to Statistical Process Control
Clinically Relevant Drug Product Specifications: Methods of Establishment
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
The X̄ Chart
The x̄ chart, often known as the individual control chart, is a crucial tool in statistical process control. It is designed to monitor process behavior and performance over time and is widely used in various industries to ensure that processes are operating at their optimum capacity and within specified limits.
A x̄ chart is constructed by plotting individual measurements of a quality characteristic in the order in which...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...